Glucocorticoid-prescribing trends in congenital adrenal hyperplasia, 2017 to 2023
Objective: This study investigates the utilisation of modern glucocorticoid medications (Acecort®, Alkindi®, Efmody®, and Plenadren®) for congenital adrenal hyperplasia due to 21-hydroxylase deficiency, examining prescribing patterns, barriers to adoption, and geographical and temporal trends. Metho...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Bioscientifica
2026-03-01
|
| Цуврал: | Endocrine Connections |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://ec.bioscientifica.com/view/journals/ec/15/3/EC-25-0565.xml |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
